emollients with keratolytics
FDA Approved
Description
Keratolytic emollients containing salicylic acid and urea are used for symptomatic management of palmoplantar keratoderma. These agents promote desquamation of hyperkeratotic skin and improve skin hydration. They represent first-line topical therapy for various inherited keratodermas.
Indications & Therapeutic Use
palmoplantar keratoderma, ichthyosis, hyperkeratosis
Linked Diseases:
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
emollients with keratolytics
| Generic Name | emollients with keratolytics |
| Brands | 1 brand available |
| Active Ingredient | salicylic acid, urea, lactic acid |
| Drug Class | palmoplantar keratoderma |
| Manufacturer | L'Oreal |
| Dosage Forms | topical cream, topical lotion, topical ointment |
| Medical Code | D02AE |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 2 days |
| Reg. Status | FDA Approved |
| Countries | 10 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations11 Validated Nodes